Literature DB >> 22573864

Specific CD8+ T cell responses correlate with control of simian immunodeficiency virus replication in Mauritian cynomolgus macaques.

Melisa L Budde1, Justin M Greene, Emily N Chin, Adam J Ericsen, Matthew Scarlotta, Brian T Cain, Ngoc H Pham, Ericka A Becker, Max Harris, Jason T Weinfurter, Shelby L O'Connor, Michael Piatak, Jeffrey D Lifson, Emma Gostick, David A Price, Thomas C Friedrich, David H O'Connor.   

Abstract

Specific major histocompatibility complex (MHC) class I alleles are associated with an increased frequency of spontaneous control of human and simian immunodeficiency viruses (HIV and SIV). The mechanism of control is thought to involve MHC class I-restricted CD8(+) T cells, but it is not clear whether particular CD8(+) T cell responses or a broad repertoire of epitope-specific CD8(+) T cell populations (termed T cell breadth) are principally responsible for mediating immunologic control. To test the hypothesis that heterozygous macaques control SIV replication as a function of superior T cell breadth, we infected MHC-homozygous and MHC-heterozygous cynomolgus macaques with the pathogenic virus SIVmac239. As measured by a gamma interferon enzyme-linked immunosorbent spot assay (IFN-γ ELISPOT) using blood, T cell breadth did not differ significantly between homozygotes and heterozygotes. Surprisingly, macaques that controlled SIV replication, regardless of their MHC zygosity, shared durable T cell responses against similar regions of Nef. While the limited genetic variability in these animals prevents us from making generalizations about the importance of Nef-specific T cell responses in controlling HIV, these results suggest that the T cell-mediated control of virus replication that we observed is more likely the consequence of targeting specificity rather than T cell breadth.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22573864      PMCID: PMC3416303          DOI: 10.1128/JVI.00716-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection.

Authors:  Cécile Chouquet; Brigitte Autran; Elisabeth Gomard; Jean-Marc Bouley; Vincent Calvez; Christine Katlama; Dominique Costagliola; Yves Rivière
Journal:  AIDS       Date:  2002-12-06       Impact factor: 4.177

2.  For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection.

Authors:  Ma Luo; Christina A Daniuk; Tamsir O Diallo; Rupert E Capina; Joshua Kimani; Charles Wachihi; Makubo Kimani; Thomas Bielawny; Trevor Peterson; Mark G R Mendoza; Sandra Kiazyk; T Blake Ball; Francis A Plummer
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS.

Authors:  A Nichole Cline; Julian W Bess; Michael Piatak; Jeffrey D Lifson
Journal:  J Med Primatol       Date:  2005-10       Impact factor: 0.667

4.  The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus.

Authors:  D A Regier; R C Desrosiers
Journal:  AIDS Res Hum Retroviruses       Date:  1990-11       Impact factor: 2.205

5.  Mitochondrial DNA of the Mauritian macaques (Macaca fascicularis): an example of the founder effect.

Authors:  S H Lawler; R W Sussman; L L Taylor
Journal:  Am J Phys Anthropol       Date:  1995-02       Impact factor: 2.868

6.  Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy.

Authors:  M Dalod; M Dupuis; J C Deschemin; D Sicard; D Salmon; J F Delfraissy; A Venet; M Sinet; J G Guillet
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

7.  HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection.

Authors:  J Tang; C Costello; I P Keet; C Rivers; S Leblanc; E Karita; S Allen; R A Kaslow
Journal:  AIDS Res Hum Retroviruses       Date:  1999-03-01       Impact factor: 2.205

8.  HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.

Authors:  M Carrington; G W Nelson; M P Martin; T Kissner; D Vlahov; J J Goedert; R Kaslow; S Buchbinder; K Hoots; S J O'Brien
Journal:  Science       Date:  1999-03-12       Impact factor: 47.728

9.  Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities.

Authors:  Nicole Frahm; B T Korber; C M Adams; J J Szinger; R Draenert; M M Addo; M E Feeney; K Yusim; K Sango; N V Brown; D SenGupta; A Piechocka-Trocha; T Simonis; F M Marincola; A G Wurcel; D R Stone; C J Russell; P Adolf; D Cohen; T Roach; A StJohn; A Khatri; K Davis; J Mullins; P J R Goulder; B D Walker; C Brander
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

10.  Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses.

Authors:  David A Price; Jason M Brenchley; Laura E Ruff; Michael R Betts; Brenna J Hill; Mario Roederer; Richard A Koup; Steven A Migueles; Emma Gostick; Linda Wooldridge; Andrew K Sewell; Mark Connors; Daniel C Douek
Journal:  J Exp Med       Date:  2005-11-14       Impact factor: 14.307

View more
  33 in total

1.  Differential impact of magnitude, polyfunctional capacity, and specificity of HIV-specific CD8+ T cell responses on HIV set point.

Authors:  Catherine Riou; Wendy A Burgers; Koleka Mlisana; Richard A Koup; Mario Roederer; Salim S Abdool Karim; Carolyn Williamson; Clive M Gray
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

Review 2.  Haplessly hoping: macaque major histocompatibility complex made easy.

Authors:  Roger W Wiseman; Julie A Karl; Patrick S Bohn; Francesca A Nimityongskul; Gabriel J Starrett; David H O'Connor
Journal:  ILAR J       Date:  2013

3.  Acute-Phase CD4+ T Cell Responses Targeting Invariant Viral Regions Are Associated with Control of Live Attenuated Simian Immunodeficiency Virus.

Authors:  Matthew S Sutton; Amy Ellis-Connell; Ryan V Moriarty; Alexis J Balgeman; Dane Gellerup; Gabrielle Barry; Andrea M Weiler; Thomas C Friedrich; Shelby L O'Connor
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

4.  Adoptive transfer of lymphocytes isolated from simian immunodeficiency virus SIVmac239Δnef-vaccinated macaques does not affect acute-phase viral loads but may reduce chronic-phase viral loads in major histocompatibility complex-matched recipients.

Authors:  Justin M Greene; Jennifer J Lhost; Paul J Hines; Matthew Scarlotta; Max Harris; Benjamin J Burwitz; Melisa L Budde; Dawn M Dudley; Ngoc Pham; Brian Cain; Caitlin E Mac Nair; Madelyn K Weiker; Shelby L O'Connor; Thomas C Friedrich; David H O'Connor
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

5.  Maintenance of AP-2-Dependent Functional Activities of Nef Restricts Pathways of Immune Escape from CD8 T Lymphocyte Responses.

Authors:  Blake Schouest; Andrea M Weiler; Sanath Kumar Janaka; Tereance A Myers; Arpita Das; Sarah C Wilder; Jessica Furlott; Melody Baddoo; Erik K Flemington; Eva G Rakasz; David T Evans; Thomas C Friedrich; Nicholas J Maness
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

6.  Vaccination with Live Attenuated Simian Immunodeficiency Virus (SIV) Protects from Mucosal, but Not Necessarily Intravenous, Challenge with a Minimally Heterologous SIV.

Authors:  Matthew S Sutton; Charles M Burns; Andrea M Weiler; Alexis J Balgeman; Andrew Braasch; Gabrielle Lehrer-Brey; Thomas C Friedrich; Shelby L O'Connor
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

7.  Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.

Authors:  Bernard Krust; Jérôme Estaquier; Ara G Hovanessian; Calaiselvy Soundaramourty; Rima Benferhat; Roger Le Grand; Nathalie Dereuddre-Bosquet
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

Review 8.  Immunopathogenesis of simian immunodeficiency virus infection in nonhuman primates.

Authors:  Joern E Schmitz; Birgit Korioth-Schmitz
Journal:  Curr Opin HIV AIDS       Date:  2013-07       Impact factor: 4.283

Review 9.  Modeling tuberculosis in nonhuman primates.

Authors:  Charles A Scanga; JoAnne L Flynn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-11       Impact factor: 6.915

10.  Acute Viral Escape Selectively Impairs Nef-Mediated Major Histocompatibility Complex Class I Downmodulation and Increases Susceptibility to Antiviral T Cells.

Authors:  Andrea M Weiler; Arpita Das; Oluwasayo Akinyosoye; Sherry Cui; Shelby L O'Connor; Elizabeth A Scheef; Jason S Reed; Antonito T Panganiban; Jonah B Sacha; Eva G Rakasz; Thomas C Friedrich; Nicholas J Maness
Journal:  J Virol       Date:  2015-12-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.